Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Translational Stroke Research
Published in: Translational Stroke Research 2/2010

Open Access 01-06-2010 | EDITORIAL

Beyond Neuroprotection to Brain Repair: Exploring the Next Frontier in Clinical Neuroscience to Expand the Therapeutic Window for Stroke

Author: Rajiv R. Ratan

Published in: Translational Stroke Research | Issue 2/2010

Login to get access

Excerpt

Stroke is the number one cause of disability in the USA; despite remarkable advancements in the primary and secondary prevention of stroke, over five million Americans (and many more of our brethren around the world) possess significant limitations in their ability to lead a quality life as a result of stroke [1]. Patients of mine who expected to retire to lives of playing golf and chasing their grandchildren instead are often relegated to a sedentary and more isolated existence. These clinical examples represent only the tip of the iceberg of the handicap and suffering that develops too often following stroke. It is thus surprising that unlike the treatment of cancer, so few clinical trials related specifically to stroke recovery are available for our patients. …
Literature
1.
Hong KS, Saver JL. Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke. Stroke. 2010;41(3):471–7. Epub 2010 Feb 4.CrossRefPubMed
2.
Mahnken JD, Mayo MS, Nudo RJ. A decision algorithm for translating preclinical trial results to enhance recovery after stroke. J Biopharm Stat. 2009;19(1):204–16.CrossRefPubMed
3.
Carmichael ST. Translating the frontiers of brain repair to treatments: starting not to break the rules. Neurobiol Dis. 2010;37(2):237–42. Epub 2009 Sep 18.CrossRefPubMed
4.
Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Neurobiol Dis. 2010;37(2):237–42. Epub 2009 Sep 18.CrossRef
5.
Xiong Y, Mahmood A, Chopp M. Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs. 2010;11(3):298–308.PubMed
6.
Arai K, Jin G, Navaratna D, Lo EH. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J. 2009;276(17):4644–52. Epub 2009 Jul 31.CrossRefPubMed
7.
Kleim JA, Chan S, Pringle E, Schallert K, Procaccio V, Jimenez R, et al. BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci. 2006;9(6):735–7. Epub 2006 May 7.CrossRefPubMed
8.
Fang PC, Barbay S, Plautz EJ, Hoover E, Strittmatter SM, Nudo RJ. Combination of NEP 1-40 treatment and motor training enhances behavioral recovery after a focal cortical infarct in rats. Stroke. 2010;41(3):544–9. Epub 2010 Jan 14.CrossRefPubMed
9.
Prusky GT, Silver BD, Tschetter WW, Alam NM, Douglas RM. Experience-dependent plasticity from eye opening enables lasting, visual cortex-dependent enhancement of motion vision. J Neurosci. 2008;28(39):9817–27.CrossRefPubMed
10.
Ma TC, Campana A, Lange PS, Lee HH, Banerjee K, Bryson JB, et al. A large-scale chemical screen for regulators of the arginase 1 promoter identifies the soy isoflavone daidzeinas a clinically approved small molecule that can promote neuronal protection or regeneration via a cAMP-independent pathway. J Neurosci. 2010;30(2):739–48.CrossRefPubMed
11.
Tillerson JL, Cohen AD, Caudle WM, Zigmond MJ, Schallert T, Miller GW. Forced nonuse in unilateral parkinsonian rats exacerbates injury. J Neurosci. 2002;22(15):6790–9.PubMed
12.
Cai D, Deng K, Mellado W, Lee J, Ratan RR, Filbin MT. Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron. 2002;35(4):711–9.CrossRefPubMed
13.
Ratan RR, Siddiq A, Smirnova N, Karpisheva K, Haskew-Layton R, McConoughey S, et al. Harnessing hypoxic adaptation to prevent, treat, and repair stroke. J Mol Med. 2007;85(12):1331–8. Epub 2007 Nov 28.CrossRefPubMed
14.
Rivieccio MA, Brochier C, Willis DE, Walker BA, D'Annibale MA, McLaughlin K, et al. HDAC6 is a target for protection and regeneration following injury in the nervous system. Proc Natl Acad Sci U S A. 2009;106(46):19599–604. Epub 2009 Nov 2.CrossRefPubMed
Metadata
Title
Beyond Neuroprotection to Brain Repair: Exploring the Next Frontier in Clinical Neuroscience to Expand the Therapeutic Window for Stroke
Author
Rajiv R. Ratan
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Translational Stroke Research / Issue 2/2010
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-010-0024-6

Other articles of this Issue 2/2010

Translational Stroke Research 2/2010 Go to the issue

Original Article

Enhanced Delivery of Erythropoietin Across the Blood–Brain Barrier for Neuroprotection Against Ischemic Neuronal Injury

Original Article

Association Between Changes in Weight and Cerebral Arteries in Rats

ORIGINAL ARTICLE

Implications of Immune System in Stroke for Novel Therapeutic Approaches

Original Article

Magnesium Sulfate Treatment Improves Outcome in Patients with Subarachnoid Hemorrhage: A Meta-analysis Study

Original Article

Ccm1 Assures Microvascular Integrity During Angiogenesis

Editorial Review

Inflammation After Stroke: Mechanisms and Therapeutic Approaches